Literature DB >> 25628388

Ensuring head and neck oncology patients receive recommended pretreatment dental evaluations.

Danielle N Margalit1, Stephanie M Losi2, Roy B Tishler2, Jonathan D Schoenfeld2, Jo Ann Fugazzotto2, Josie Stephens2, Amy L Cebulski2, Elizabeth L Hammerstrand2, Laura Ma2, Holly M Lopes2, Robert I Haddad2, Nathaniel S Treister2, Jennifer L Frustino2.   

Abstract

PURPOSE: Head and neck (H&N) cancer therapy can have a detrimental effect on oral health by increasing the risk of dry mouth, dental caries, dental infection, and osteonecrosis of the jaw. Pretreatment dental evaluations are recommended for patients with H&N cancer before radiation therapy to minimize the risk of acute and long-term adverse effects. In an earlier effort to educate patients and community dentists about the importance of pretreatment dental evaluations, we created a dental instructional guide (DIG) that outlines the necessary components of the preradiation dental evaluation. Yet our program did not have a system for documenting which patients received the DIG. The aim of this project was to create a reliable system to ensure that patients are given the DIG before radiation therapy and that such patients are readily identifiable, allowing us to confirm that their dental evaluations are complete before starting treatment.
METHODS: We implemented a tracking template within the H&N oncology program at the Dana-Farber Cancer Institute that documents the date, patient, and clinician who gave the DIG. We used the Model for Improvement methodology and performed plan-do-study-act (PDSA) cycles to test and monitor the results of the template implementation.
RESULTS: We showed a significant improvement in the rate of DIG documentation from a baseline of 0% (range, 0% to 0%) to a mean of 53% (range, 0% to 100%) over 3 months (P < .01).
CONCLUSION: This intervention was the first step in creating a sustainable system for ensuring timely preradiation dental evaluation, thereby decreasing the risk of dental complications from H&amp;N cancer therapy.
Copyright © 2015 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2015        PMID: 25628388     DOI: 10.1200/JOP.2014.000414

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  5 in total

1.  Radiology as the Point of Cancer Patient and Care Team Engagement: Applying the 4R Model at a Patient's Breast Cancer Care Initiation.

Authors:  Christine B Weldon; Sarah M Friedewald; Swati A Kulkarni; Melissa A Simon; Ruth C Carlos; Jonathan B Strauss; Mikele M Bunce; Art Small; Julia R Trosman
Journal:  J Am Coll Radiol       Date:  2016-12       Impact factor: 5.532

Review 2.  The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.

Authors:  Ahmed Sultan; Glenn J Hanna; Danielle N Margalit; Nicole Chau; Laura A Goguen; Francisco M Marty; Guilherme Rabinowits; Jonathan D Schoenfeld; Stephen T Sonis; Tom Thomas; Roy B Tishler; Nathaniel S Treister; Alessandro Villa; Sook-Bin Woo; Robert Haddad; Hani Mawardi
Journal:  Oncologist       Date:  2017-02-16

3.  Oncology Curricula in Postgraduate General Dentistry Programs: a Survey of Residency Program Directors.

Authors:  Evan B Rosen; Alexander Drew; Joseph M Huryn
Journal:  J Cancer Educ       Date:  2019-04       Impact factor: 2.037

4.  Effects of continuity of care on the postradiotherapy survival of working-age patients with oral cavity cancer: A nationwide population-based cohort study in Taiwan.

Authors:  Tsu Jen Kuo; Pei Chen Wu; Pei Ling Tang; Chun-Hao Yin; Chi Hsiang Chu; Yao-Min Hung
Journal:  PLoS One       Date:  2019-12-16       Impact factor: 3.240

5.  Differences in perceived intra-oral dryness in various dry-mouth patients as determined using the Regional Oral Dryness Inventory.

Authors:  Z Assy; C P Bots; H Z Arisoy; S S Gülveren; F J Bikker; H S Brand
Journal:  Clin Oral Investig       Date:  2021-01-26       Impact factor: 3.573

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.